Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
12
×
Tags
boston
12
×
boston blog main
national blog main
national top stories
12
×
startups
12
×
boston top stories
life sciences
biotech
vc
deals
new york blog main
san francisco blog main
software
clinical trials
investing
venture capital
healthcare
medical devices
cancer
fda
gene therapy
new york top stories
people
san diego blog main
san francisco top stories
sanofi
seattle blog main
texas blog main
third rock ventures
38 studios
accelerator
adeno-associated virus
aidan petrie
allosteric
alnylam pharmaceuticals
amazon
american well
amy schulman
andreas klein
andreessen horowitz
What
medicines
new
startup
drugs
therapeutics
years
adding
ago
aiming
aims
approach
called
ceo
fix
gene
healthcare
medical
million
research
science
turn
acquire
acquisition
address
adds
allosteric
amazon’s
andreessen
announced
answer
aren’t
atrial
backed
balance
based
better
bio
biotech
boston
boston’s
Language
unset
Current search:
photo
×
boston
×
" national top stories "
×
startups
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”